Scholar Rock Holding Co. (NASDAQ:SRRK – Get Free Report) insider Tracey Sacco sold 6,500 shares of the stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $33.08, for a total transaction of $215,020.00. Following the transaction, the insider now directly owns 71,750 shares in the company, valued at $2,373,490. This trade represents a 8.31 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Scholar Rock Stock Down 1.6 %
Shares of NASDAQ SRRK traded down $0.53 during trading on Tuesday, hitting $33.28. The stock had a trading volume of 1,198,919 shares, compared to its average volume of 1,149,807. The firm has a fifty day moving average of $38.40 and a two-hundred day moving average of $32.72. The company has a market capitalization of $3.15 billion, a PE ratio of -14.16 and a beta of 0.59. The company has a debt-to-equity ratio of 0.63, a current ratio of 3.88 and a quick ratio of 3.88. Scholar Rock Holding Co. has a 12 month low of $6.76 and a 12 month high of $46.98.
Institutional Investors Weigh In On Scholar Rock
A number of institutional investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its position in shares of Scholar Rock by 51.8% during the 4th quarter. GAMMA Investing LLC now owns 788 shares of the company’s stock worth $34,000 after buying an additional 269 shares in the last quarter. Quarry LP increased its position in shares of Scholar Rock by 3,443.3% during the third quarter. Quarry LP now owns 4,500 shares of the company’s stock valued at $36,000 after acquiring an additional 4,373 shares during the last quarter. Global Retirement Partners LLC lifted its holdings in Scholar Rock by 584.7% during the fourth quarter. Global Retirement Partners LLC now owns 897 shares of the company’s stock worth $39,000 after acquiring an additional 766 shares during the period. Nisa Investment Advisors LLC boosted its position in Scholar Rock by 1,321.8% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,109 shares of the company’s stock worth $48,000 after purchasing an additional 1,031 shares during the last quarter. Finally, GF Fund Management CO. LTD. bought a new position in Scholar Rock in the 4th quarter valued at $85,000. 91.08% of the stock is owned by institutional investors.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on Scholar Rock
Scholar Rock Company Profile
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.
Featured Articles
- Five stocks we like better than Scholar Rock
- What is the Hang Seng index?
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- What does consumer price index measure?
- NVIDIA Insiders Sell: This Is What It Means for the Market
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Scholar Rock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scholar Rock and related companies with MarketBeat.com's FREE daily email newsletter.